# APELLIS PHARMACEUTICALS INC (APLS) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 03753U106
Page URL: https://superinvestorclub.com/stock/APLS
Last updated: 2026-07-08T13:35:13.638Z

## Summary

As of the most recent 13F filing period, APELLIS PHARMACEUTICALS INC (APLS) is held by 1 tracked superinvestors with an aggregate position value of $1.4M representing 034913 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 34913 | $1.4M | 0.01% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2025-12-31: 1 holders, $3.6M aggregate, 0143805 shares
- 2026-03-31: 1 holders, $1.4M aggregate, 034913 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "APELLIS PHARMACEUTICALS INC (APLS) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/APLS), aggregating SEC 13F, Form 4, and congressional disclosures."